Macrocyclic inhibitors of hepatitis C virus

Inhibitors of HCV of formula (I), and the -oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R is hydrogen or Calkyl; R is hydrogen or Calkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and...

Full description

Saved in:
Bibliographic Details
Main Authors ANTONOV, DMITRY, RABOISSON, PIERRE JEAN-MARIE BERNARD, DE KOCK, HERMAN AUGUSTINUS, KAHNBERG, PIA CECILIA, ROSENQUIST, ASA ANNICA KRISTINA, SAMUELSSON, BENGT BERTIL, LINDSTROM, MATS STEFAN, SIMMEN, KENNETH ALAN, NILSSON, KARL MAGNUS
Format Patent
LanguageEnglish
Published 29.11.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Inhibitors of HCV of formula (I), and the -oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R is hydrogen or Calkyl; R is hydrogen or Calkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
Bibliography:Application Number: AU20060274857